Education
About Us
Working with TipRanks
Follow Us
Electrocore Llc (ECOR)
NASDAQ:ECOR
ECOR Stock Chart & Stats
$7.61
$0.45(2.64%)
At close: 4:00 PM EST
$7.61
$0.45(2.64%)
Day’s Range― - ―
52-Week Range$4.16 - $15.68
Previous CloseN/A
Volume24.66K
Average Volume (3M)33.66K
Market Cap
$60.85M
Enterprise Value$66.47M
Total Cash (Recent Filing)$13.20M
Total Debt (Recent Filing)$10.81M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Mar 05, 2026EPS Estimate
-0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,995,903
10 Day Avg. Volume29,982
30 Day Avg. Volume33,656
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)16.08
Price to Sales (P/S)4.82
P/FCF Ratio-17.46
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue2.23
Enterprise Value/Gross Profit2.59
Enterprise Value/Ebitda-5.24
Forecast
1Y Price Target
$15.00Price Target Upside97.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.84
Revenue Forecast (FY)$44.79M
Bulls Say, Bears Say
Bulls Say
Clinical Study And Regulatory ExpansionAn ongoing clinical study testing the device as an adjunctive treatment for post-traumatic stress disorder could enable pursuit of an expanded regulatory indication and broader adoption within the Veterans Affairs healthcare system if results are favorable.
Revenue Guidance And CommercializationPreliminary full-year revenues matched management guidance and analyst consensus, reinforcing progress in commercializing the vagus nerve stimulation platform and supporting revenue expectations.
Salesforce Expansion And Commercial UptakePlans to expand the salesforce combined with strong commercial uptake of new devices and product introductions support projected revenue growth and higher market penetration.
Bears Say
Legal Expense Impact On ProfitabilityWidened GAAP loss per share estimates tied to anticipated legal expenses increase pressure on profitability and could weigh on future earnings expectations.
Liquidity And Cash BurnA declining cash balance signals ongoing cash burn that could create liquidity pressure and necessitate additional financing to sustain operations.
Operating Expenses And Interest BurdenHigher operating expenses, rising interest costs, and expected litigation fees have led analysts to lower price targets, exerting downward pressure on valuation.
Electrocore News
ECOR FAQ
What was Electrocore Llc’s price range in the past 12 months?
Electrocore Llc lowest stock price was $4.16 and its highest was $15.68 in the past 12 months.
What is Electrocore Llc’s market cap?
Electrocore Llc’s market cap is $60.85M.
When is Electrocore Llc’s upcoming earnings report date?
Electrocore Llc’s upcoming earnings report date is Mar 05, 2026 which is today.
How were Electrocore Llc’s earnings last quarter?
Currently, no data Available
Is Electrocore Llc overvalued?
According to Wall Street analysts Electrocore Llc’s price is currently Undervalued.
Does Electrocore Llc pay dividends?
Electrocore Llc does not currently pay dividends.
What is Electrocore Llc’s EPS estimate?
Electrocore Llc’s EPS estimate is -0.38.
How many shares outstanding does Electrocore Llc have?
Electrocore Llc has 7,995,903 shares outstanding.
What happened to Electrocore Llc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Electrocore Llc?
Currently, no hedge funds are holding shares in ECOR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electrocore Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (97.11% Upside)
$15.00 (97.11% Upside)
Insider Transactions
Sold Shares
Worth $12.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.72%
12-Months-Change
Fundamentals
Return on Equity
-337.84%
Trailing 12-Months
Asset Growth
1.74%
Trailing 12-Months
Company Description
Electrocore Llc
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
ECOR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful strategic initiatives such as the NeuroMetrix acquisition and expansion in the VA system. However, these were balanced by increased net losses, delayed profitability, and ongoing legal challenges. Overall, the company is investing heavily in its future, which may pay off, but current financials are impacted.View all ECOR earnings summariesECOR Stock 12 Month Forecast
Average Price Target
$15.00
▲(97.11% Upside)
Technical Analysis
Myomo
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
21.74% Insiders
3.30% Mutual Funds
3.66% Other Institutional Investors
68.60% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---